Genomic Health, Inc. (NASDAQ:GHDX)’s share price traded down 5.9% on Wednesday following insider selling activity. The company traded as low as $25.51 and last traded at $25.79, with a volume of 206,620 shares changing hands. The stock had previously closed at $27.42. Specifically, COO G Bradley Cole sold 5,000 shares of Genomic Health stock in […]
